Position in GNLX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$17,281
-$13,853 QoQ
Shares Held
7,141
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WHITTIER TRUST CO OF NEVADA INC holds $887,716 across 26 Biotechnology names. GNLX ranks #11 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
569 | $254,081 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,200 | $149,226 | |
| 3 | INSM |
INSMED Inc
|
444 | $72,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
219 | $72,460 | |
| 5 | ANRO |
Alto Neuroscience, Inc.
|
2,482 | $55,795 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69 | $53,312 | |
| 7 | TECH |
BIO-TECHNE Corp
|
986 | $51,528 | |
| 8 | CGON |
CG Oncology, Inc.
|
666 | $45,074 |
All Filings in GNLX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,281 | 7,141 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $31,134 | 7,141 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $29,992 | 7,141 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $20,494 | 7,141 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $19,280 | 7,141 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $16,852 | 7,141 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,924 | 7,141 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $13,924 | 7,141 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $45,916 | 7,141 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $100,045 | 7,141 | Shares | Sole | 2024-01-11 | |
| No filing history on record for this holder in this stock. | ||||||